<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04804748</url>
  </required_header>
  <id_info>
    <org_study_id>IPPMed Defipace 202103</org_study_id>
    <nct_id>NCT04804748</nct_id>
  </id_info>
  <brief_title>The DefiPace Study</brief_title>
  <official_title>Safety and Efficacy of Low-energy Electrical Cardioversion With or Without Bi-atrial Pacing in Patients With Post-operative Atrial Fibrillation in a Real World Setting - The DefiPace Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut f체r Pharmakologie und Pr채ventive Medizin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Osypka AG Medizintechnik</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut f체r Pharmakologie und Pr채ventive Medizin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, non-interventional, multi-center, international registry in two phases in&#xD;
      consecutive patients undergoing elective cardiac surgery.&#xD;
&#xD;
      The DefiPace registry is designed in two phases&#xD;
&#xD;
        1. to document the standard of care in 50 patients with atrial fibrillation (AF)&#xD;
&#xD;
        2. to assess the treatment and outcomes of patients with post-operative atrial&#xD;
           fibrilllation using low-energy cardioversion and subsequent bi-atrial pacing in clinical&#xD;
           practice in 100 patients&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Phase A Approximately 150 consecutive patients undergoing elective cardiac surgery (bypass&#xD;
      and / or valve surgery)&#xD;
&#xD;
        -  Data regarding standard of care post-operative pacing and treatment of POAF, if&#xD;
           applicable, will be collected from time of surgery until discharge&#xD;
&#xD;
        -  No use of an external bi-atrial pacing device&#xD;
&#xD;
        -  No use of Defipace&#xD;
&#xD;
        -  In-hospital data will be collected for all patients&#xD;
&#xD;
        -  Patients that developed POAF (n=50) will be followed-up with a phone call 30 days after&#xD;
           surgery.&#xD;
&#xD;
      Phase B Approximately 300 consecutive patients undergoing elective cardiac surgery (bypass&#xD;
      and / or valve surgery) with planned TMA implantation&#xD;
&#xD;
        -  In-hospital data will be collected for all patients&#xD;
&#xD;
        -  Use of the DefiPace system for the treatment (low-energy cardioversion) and&#xD;
           post-operative prevention (bi-atrial pacing) of POAF will be documented (n=100). These&#xD;
           patients will be followed-up with a phone call 30 days after surgery&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 15, 2021</start_date>
  <completion_date type="Anticipated">January 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of POAF</measure>
    <time_frame>30 days</time_frame>
    <description>Incidence of POAF</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Termination of POAF</measure>
    <time_frame>30 days</time_frame>
    <description>Termination of POAF</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time in POAF</measure>
    <time_frame>30 days</time_frame>
    <description>Time in POAF (AF Burden)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to cardioversion</measure>
    <time_frame>30 days</time_frame>
    <description>Median time to cardioversion</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of shocks</measure>
    <time_frame>30 days</time_frame>
    <description>Mean number of shocks per patient</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Energy requirements</measure>
    <time_frame>30 days</time_frame>
    <description>Mean energy requirements (first/subsequent)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>POAF recurrence</measure>
    <time_frame>30 days</time_frame>
    <description>POAF recurrence/repeat cardioversions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time in ICU</measure>
    <time_frame>30 days</time_frame>
    <description>Time in ICU in hours</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Procedural success</measure>
    <time_frame>30 days</time_frame>
    <description>Procedural success</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time needed for electrode placement</measure>
    <time_frame>30 days</time_frame>
    <description>Time needed for electrode placement</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">450</enrollment>
  <condition>Post-operative Atrial Fibrillation POAF</condition>
  <arm_group>
    <arm_group_label>Phase A</arm_group_label>
    <description>Approximately 150 consecutive patients undergoing elective cardiac surgery (bypass and / or valve surgery)&#xD;
Data regarding standard of care post-operative pacing and treatment of POAF, if applicable, will be collected from time of surgery until discharge&#xD;
No use of an external bi-atrial pacing device&#xD;
No use of Defipace&#xD;
In-hospital data will be collected for all patients&#xD;
Patients that developed POAF (n=50) will be followed-up with a phone call 30 days after surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase B</arm_group_label>
    <description>Approximately 300 consecutive patients undergoing elective cardiac surgery (bypass and / or valve surgery) with planned TMA implantation&#xD;
In-hospital data will be collected for all patients&#xD;
Use of the DefiPace system for the treatment (low-energy cardioversion) and post-operative prevention (bi-atrial pacing) of POAF will be documented (n=100). These patients will be followed-up with a phone call 30 days after surgery</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Phase A Approximately 150 consecutive patients undergoing elective cardiac surgery (bypass&#xD;
        and / or valve surgery) Phase B Approximately 300 consecutive patients undergoing elective&#xD;
        cardiac surgery (bypass and / or valve surgery) with planned TMA implantation.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient is scheduled to undergo elective open chest cardiac surgery (bypass and / or&#xD;
             valve surgery)&#xD;
&#xD;
          -  Patient with isolated bypass surgery is at least 70 years old&#xD;
&#xD;
          -  Patient with valve surgery is at least 60 years old&#xD;
&#xD;
          -  Patient provides written informed consent prior to the procedure&#xD;
&#xD;
          -  Phase B only: patient is scheduled for TMA implantation during the elective cardiac&#xD;
             surgery and is potentially eligible for DefiPace use&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Permanent AF at hospital admission&#xD;
&#xD;
          -  Permanent pacemaker/defibrillator, other intra-cardiac active implanted electronic&#xD;
             devices&#xD;
&#xD;
          -  Minimally-invasive surgery&#xD;
&#xD;
          -  Recent stroke within the last 3 months&#xD;
&#xD;
          -  A history of or current endocarditis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Peter Bramlage, Professor</last_name>
    <role>Study Director</role>
    <affiliation>IPPMed</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Beate Botta, PhD</last_name>
    <phone>+49 447185033</phone>
    <phone_ext>25</phone_ext>
    <email>beate.botta@ippmed.de</email>
  </overall_contact>
  <reference>
    <citation>Bechtel JF, Christiansen JF, Sievers HH, Bartels C. Low-energy cardioversion versus medical treatment for the termination of atrial fibrillation after CABG. Ann Thorac Surg. 2003 Apr;75(4):1185-8.</citation>
    <PMID>12683560</PMID>
  </reference>
  <reference>
    <citation>Liebold A, Wahba A, Birnbaum DE. Low-energy cardioversion with epicardial wire electrodes: new treatment of atrial fibrillation after open heart surgery. Circulation. 1998 Sep 1;98(9):883-6.</citation>
    <PMID>9738643</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>March 16, 2021</study_first_submitted>
  <study_first_submitted_qc>March 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 18, 2021</study_first_posted>
  <last_update_submitted>August 24, 2021</last_update_submitted>
  <last_update_submitted_qc>August 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

